Document Detail


Pressor and vascular effects of cardiac glycosides.
MedLine Citation:
PMID:  11525236     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: For the past two decades, it has generally been accepted ('Blaustein hypothesis') that cardiac glycosides such as ouabain and digoxin increase the sodium and calcium content of smooth muscle cells, so inducing arterial vasoconstriction and a rise in blood pressure. Recent data from an experimental study we carried out led us to question this assumption. DESIGN: A retrospective literature survey covering 20 years and including animal and human studies was performed. Representative results are presented. RESULTS: Contradictory effects of cardiac glycosides on blood pressure and vasculature have been described. Increased, decreased or unaltered blood-pressure values have been observed following administration of the glycosides ouabain, digoxin and digitoxin. Moreover, vasoconstricting as well as vasodilating effects of cardiac glycosides have been demonstrated. Several recent studies show that cardiac glycosides such as digoxin and digitoxin can lead to a reduction of at least diastolic blood pressure. CONCLUSION: A slight vasodilation of resistance vessels followed by a fall in diastolic blood pressure could be a contributing factor for the beneficial effects of cardiac glycosides in patients with congestive heart failure. This vasodilation may be caused by central (neurohumoral) effects of digitalis glycosides.
Authors:
W Kirch
Related Documents :
8980426 - The importance of transesophageal echocardiography during surgery of the thoracic aorta.
7103716 - Cardiac performance testing by volume loading and lower-extremity compression.
8041516 - Calcitonin gene-related peptide (human alpha-cgrp) counteracts vasoconstriction in huma...
1290186 - Low-output syndrome after heart surgery: is a monotherapy with phosphodiesterase-iii in...
17547656 - During measurements of root hydraulics with pressure probes, the contribution of unstir...
11603236 - Pharmacist-managed hypertension therapy conversion.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European journal of clinical investigation     Volume:  31 Suppl 2     ISSN:  0014-2972     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2001  
Date Detail:
Created Date:  2001-08-29     Completed Date:  2001-12-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  5-9     Citation Subset:  IM    
Affiliation:
Institute of Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany. arras@rcs.urz.tu-dresden.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects*
Cardiac Glycosides / pharmacology*
Cardiotonic Agents / pharmacology*
Humans
Vasoconstriction / drug effects*
Chemical
Reg. No./Substance:
0/Cardiac Glycosides; 0/Cardiotonic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of cardiac glycosides on 24-h ambulatory blood pressure in healthy volunteers and patients w...
Next Document:  Self-cytoprotection against stress: feedback regulation of heme-dependent metabolism.